Protective effects of curcumin against rotenone and salsolinol-induced toxicity: Implications for parkinson's disease

Neurotoxicity Research

Volumn 25, Issue 1, 2014, Pages 81-89

  Qualls, Zakiya ^a   Brown, Dwayne ^a   Ramlochansingh, Carlana ^a   Hurley, Laura L ^a   Tizabi, Yousef ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cell flow cytometry; Curcumin; Parkinson's disease; Rotenone; Salsolinol; SH SY5Y cells

Indexed keywords

CASPASE 3; CURCUMIN; ROTENONE; SALSOLINOL; ANTIPARKINSON AGENT; INSECTICIDE; ISOQUINOLINE DERIVATIVE; NEUROPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE DEGENERATION; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; CELL SURVIVAL; DRUG EFFECTS; DRUG INTERACTION; TUMOR CELL LINE;

ANTIPARKINSON AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DOPAMINERGIC NEURONS; DRUG INTERACTIONS; HUMANS; INSECTICIDES; ISOQUINOLINES; NEUROPROTECTIVE AGENTS; ROTENONE;

EID: 84891857945     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9433-0     Document Type: Article

References (50)

1. Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41:40-59
2. Aggarwal BB, Sundaram C, Malani N, Ichikawa H (2007) Curcumin: the Indian solid gold. Adv Exp Med Biol 595:1-75
3. Alam M, Schmidt WJ (2002) Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res 136:317-324 (Pubitemid 35246417)
4. Alladi PA, Mahadevan A, Yasha TC, Raju TR, Shankar SK, Muthane U (2009) Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: relevance to lower incidence of Parkinson's disease. Neuroscience 159:236-245
5. Antkiewicz-Michaluk L (2002) Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines. Pol J Pharmacol 54:567-572 (Pubitemid 36124505)
6. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3:1301-1306
7. Bhutani MK, Bishnoi M, Kulkarni SK (2009) Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav 92:39-43
8. Brown D, Tamas A, Reglodi D, Tizabi Y (2013) PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease. J Mol Neurosci 50:600-607
9. Caboni P, Sherer TB, Zhang N, Taylor G, Na HM, Greenamyre JT, Casida JE (2004) Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem Res Toxicol 17:1540-1548 (Pubitemid 39532322)
10. Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, Ganguli M (2001) Incidence of Alzheimer's disease in a rural community in India: the Indo-US study. Neurology 57:985-989 (Pubitemid 32880190)
11. Chinta SJ, Ganesan A, Reis-Rodrigues P, Lithgow GJ, Andersen JK (2013) Anti-inflammatory role of the isoflavone diadzein in lipopolysaccharide- stimulated microglia: implications for Parkinson's disease. Neurotox Res 23:145-153
12. Copeland RL Jr, Leggett YA, Kanaan YM, Taylor RE, Tizabi Y (2005) Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: implications for Parkinson's disease. Neurotox Res 8:289-293
13. Copeland RL Jr, Das JR, Kanaan YM, Taylor RE, Tizabi Y (2007) Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res 12:61-69
14. Darvesh AS, Carroll RT, Bishayee A, Novotny NA, Geldenhuys WJ, Van der Schyf CJ (2012) Curcumin and neurodegenerative diseases: a perspective. Expert Opin Investig Drugs 21:1123-1140
15. Das JR, Tizabi Y (2009) Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells. Neurotox Res 16:194-204
16. Dostert P, Strolin Benedetti M, Dordain G (1988) Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases. J Neural Transm 74:61-74
17. Freestone PS, Chung KK, Guatteo E, Mercuri NB, Nicholson LF, Lipski J (2009) Acute action of rotenone on nigral dopaminergic neurons-involvement of reactive oxygen species and disruption of Ca2 + homeostasis. Eur J Neurosci 30:1849-1859
18. Gao HM, Hong JS, Zhang W, Liu B (2002) Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 22:782-790 (Pubitemid 34141759)
19. Gao HM, Hong JS, Zhang W, Liu B (2003a) Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci 23:1228-1236 (Pubitemid 36258901)
20. Gao HM, Liu B, Hong JS (2003b) Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 23:6181-6187 (Pubitemid 36875618)
21. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AH (1994) Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem 63:1987-1990 (Pubitemid 24326248)
22. Hoglinger GU, Feger J, Prigent A, Michel PP, Parain K, Champy P, Ruberg M, Oertel WH, Hirsch EC (2003) Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 84:491-502 (Pubitemid 36182248)
23. Hurley LL, Akinfiresoye L, Nwulia E, Kamiya A, Kulkarni AA, Tizabi Y (2013) Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF. Behav Brain Res 239:27-30
24. Jurenka JS (2009) Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alternative Med Rev 14:141-153
25. Kulkarni SK, Bhutani MK, Bishnoi M (2008) Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology 201:435-442
26. Leng A, Feldon J, Ferger B (2003) Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum. Synapse 50:240-250 (Pubitemid 37315354)
27. Li YC, Wang FM, Pan Y, Qiang LQ, Cheng G, Zhang WY, Kong LD (2009) Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry 33:435-449
28. Loas G, Krystkowiak P, Godefroy O (2012) Anhedonia in Parkinson's disease: an overview. J Neuropsychiatry Clin Neurosci 24:444-451
29. Maruyama W, Dostert P, Matsubara K, Naoi M (1995) N-Methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Radical Biol Med 19:67-75
30. Moser A, Siebecker F, Vieregge P, Jaskowski P, Kompf D (1996) Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease. J Neural Transm 103:421-432 (Pubitemid 26131743)
31. Moussa CE, Rusnak M, Hailu A, Sidhu A, Fricke ST (2008) Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies. Exp Neurol 209:224-233
32. Mravec B (2006) Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: a review of recent developments. Physiol Res 55:353-364 (Pubitemid 44291092)
33. Muthane U, Yasha TC, Shankar SK (1998) Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol 43:283-287 (Pubitemid 28113589)
34. Nagatsu T (1997) Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci Res 29:99-111 (Pubitemid 27422504)
35. Naoi M, Maruyama W, Matsubara K, Hashizume Y (1997) A neutral N-methyltransferase activity in the striatum determines the level of an endogenous MPP+-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brains. Neurosci Lett 235:81-84 (Pubitemid 27471110)
36. Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH (2006) Curry consumption and cognitive function in the elderly. Am J Epidemiol 164:898-906 (Pubitemid 44627275)
37. Ramlochansingh C, Taylor RE, Tizabi Y (2011) Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated. Neurotox Res 20:263-269
38. Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R (1995) Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 94:79-83
39. Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G, Aggarwal BB (2007a) Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radical Biol Med 43:568-580 (Pubitemid 47058232)
40. Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB (2007b) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28:1765-1773 (Pubitemid 47289040)
41. Sharma OP (1976) Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25:1811-1812
42. Song JX, Shaw PC, Wong NS, Sze CW, Yao XS, Tang CW, Tong Y, Zhang YB (2012) Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP(+), but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells. Neurosci Lett 521:76-81
43. Starkstein SE, Brockman S, Hayhow BD (2012) Psychiatric syndromes in Parkinson's disease. Curr Opin Psychiatry 25:468-472
44. Storch A, Kaftan A, Burkhardt K, Schwarz J (2000) 1-Methyl-6,7-dihydroxy- 1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res 855:67-75 (Pubitemid 30067695)
45. Tieu K (2011) A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harb Perspect Med 1:a009316
46. Vas CJ, Pinto C, Panikker D, Noronha S, Deshpande N, Kulkarni L, Sachdeva S (2001) Prevalence of dementia in an urban Indian population. IPA 13:439-450 (Pubitemid 34326972)
47. Worth PF (2013) How to treat Parkinson's disease in 2013. Clin Med 13:93-96
48. Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J 123:1086-1092
49. Xu Y, Ku BS, Yao HY, Lin YH, Ma X, Zhang YH, Li XJ (2005) Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacol Biochem Behav 82:200-206 (Pubitemid 41423504)
50. Zhang Y, Wang L, Mu X, Duan J, Zhu Y, Qing H, Li Y, Xiao S, Deng Y (2011) Assessment of salsolinol N-methyltransferase activity in rat peripheral lymphocytes by liquid chromatography-electrospray time-of-flight mass spectrometry. Anal Bioanal Chem 399:3541-3545